FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 500000 ug/5000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Potassium Chloride; Magnesium Sulfate Heptahydrate; Lidocaine | 1.94 g/1052.8 mL; 2 g/1052.8 mL; .13 g/1052.8 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 140 mg/7 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 200 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 300000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 500 g/5000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2 g/100 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 1000 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2000 mg/20 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 3 g/100 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 300000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Dextrose Monohydrate | 25000 mg/50 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Dextrose Monohydrate | 1500000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Diltiazem Hydrochloride | 15000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Hydrochloride | 15000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Hydrochloride | 30000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 25 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 150000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ephedrine Sulfate | 50 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl | 30000 ug/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2500 ug/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 1000 ug/100 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone | 5400 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 900 mg/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 10 mg/50 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 6 mg/30 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 50 mg/50 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine | 30000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 20 mg/2 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 75000 mg/1500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol | 15000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 |